Track topics on Twitter Track topics that are important to you
A new technique shows high potential for providing a discrete, non-invasive biomarker of Alzheimer's disease (AD) at the individual level during both preclinical and clinical stages. The proposed biomarker has a large effect size (0.9) and high accuracy, sensitivity and specificity (100 percent) in identifying symptomatic AD patients within a research sample, according to Sanja Josef Golubić Ph.D. of the University of Zagreb. He is the leading author of a new study published in the neuroimaging journal Human Brain Mapping.NEXT ARTICLE
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...